Study Stopped
recruiting problems
Sleep Deprivation and Advancement of Sleep Period as Treatment for Bipolar Depression.
Sleep Deprivation and Three Days Sleep Phase Advancement as Treatment for Bipolar Depression.
1 other identifier
interventional
5
1 country
1
Brief Summary
The purpose of this study is to determine if sleep deprivation and sleep phase advancement is effective treatment of bipolar patients in a depressive phase.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2005
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2005
CompletedFirst Posted
Study publicly available on registry
September 29, 2005
CompletedStudy Start
First participant enrolled
October 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedApril 9, 2012
April 1, 2012
6.2 years
September 27, 2005
April 6, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Scores on rating scales for depression and symptom severity.
one month
Secondary Outcomes (1)
Scores on rating scales for anxiety, mania, cognitive processing, and sleep quality.
one month
Study Arms (2)
Sleep deprivation
EXPERIMENTALSleep deprivation and sleep phase advancement
usual treatment
ACTIVE COMPARATORInterventions
Total sleep deprivation from 0800 to 1700 next day, and three day sleep phase advancement following sleep deprivation.
Treatment as usual in the psychiatric ward. Patients in this group will be offered treatment with sleep deprivation and sleep phase advancement after five weeks if they still meet inclusion criteria
Eligibility Criteria
You may qualify if:
- Bipolar disorder, depressive phase
You may not qualify if:
- substance abuse, psychotic symptoms, suicidal intentions, active mania/hypomania.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Norwegian University of Science and Technology, Institute of Neuroscience
Trondheim, 7489, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gunnar Morken, PhD MD
Norwegian University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 27, 2005
First Posted
September 29, 2005
Study Start
October 1, 2005
Primary Completion
December 1, 2011
Study Completion
December 1, 2011
Last Updated
April 9, 2012
Record last verified: 2012-04